trial · primary record
Biospecimen Collection
Accelerated Phase Myeloproliferative Neoplasm
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 78 |
| Primary completion | 2027-12-31 |
| Primary endpoint | Acute leukemia response-complete (ALR-C) rate |
| Registry ID | NCT06661915 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:14.409Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT06661915
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.